More lessons for the treatment of chronic daily headache

Journal of Headache and Pain

Volumn 9, Issue 1, 2008, Pages 3-4

  Pascual, Julio ^a   Cacabelos, Purificación ^a  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BOTULINUM TOXIN A; ERGOT DERIVATIVE; OPIATE DERIVATIVE; PLACEBO; TOPIRAMATE; VALPROIC ACID;

CHRONIC DAILY HEADACHE; CLINICAL PRACTICE; CLINICAL TRIAL; CONSULTATION; DRUG EFFICACY; DRUG POTENTIATION; DRUG WITHDRAWAL; EDITORIAL; HUMAN; LOW DRUG DOSE; MANAGED CARE; PATIENT CARE; PRIORITY JOURNAL; TRANSFORMED MIGRAINE;

ADRENERGIC BETA-ANTAGONISTS; ANALGESICS; ANTICONVULSANTS; CLINICAL PROTOCOLS; CLINICAL TRIALS AS TOPIC; DRUG ADMINISTRATION SCHEDULE; ELECTRIC STIMULATION THERAPY; FRUCTOSE; HEADACHE DISORDERS; HUMANS; NEUROMUSCULAR BLOCKING AGENTS; SUBSTANCE WITHDRAWAL SYNDROME; VALPROIC ACID;

EID: 39549119130     PISSN: 11292369     EISSN: 11292377     Source Type: Journal    
DOI: 10.1007/s10194-008-0010-5     Document Type: Editorial

References (12)

1. Yurekli VA, Akhan G, Kutluhan S, Uzar E, Uzar E, Koyuncuoglu HR, Gultekin F (2008) The effect of sodium valproate on chronic daily headache and its subgroups. J Headache Pain 9. 10.1007/s10194-008-0002-5
2. Mathew NT, Ali S (1991) Valproate in the treatment of persistent chronic daily headache. An open label study. Headache 31:71-74
3. Freitag FG, Diamond S, Diamond ML, Urban GJ (2001) Divalproex in the long-term treatment of chronic daily headache. Headache 41:271-278
4. Silvestrini M, Bartolini M, Coccia M, Barufaldi R, Taffi R, Provinciali L (2003) Topiramate in the treatment of chronic migraine. Cephalalgia 23:820-824
5. Silberstein SD, Lipton RB, Dodick DW, Freitag FG, Ramadan N, Mathew N, Brandes JL, Bigal M, Saper J, Ascher S, Jordan DM, Greenberg SJ, Hulihan J; Topiramate Chronic Migraine Study Group (2007) Efficacy and safety of topiramate for the treatment of chronic migraine: A randomized, double-blind, placebo-controlled trial. Headache 47:170-180
6. Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ, TIPMAT-MIG 201 (TOP-CHROME) Study Group (2007) Topiramate reduces headache days in chronic migraine: A randomized, double-blind, placebo-controlled study. Cephalalgia 27:814-823
7. Pascual J, Leira R, Lainez JM (2003) Combined therapy for migraine prevention? Clinical experience with a beta-blocker plus sodium valpoate in 52 resistant migraine patients. Cephalalgia 23:961-962
8. Pascual J, Rivas MT, Leira R (2007) Testing the combination beta-blocker plus topiramate in refractory migraine. Acta Neurol Scand 115:81-83
9. Pascual J, El Berdei Y, Gómez-Sánchez JC (2007) How many migraine patients need prolonged (>1 year) preventive treatment? Experience with topiramate. J Headache Pain 8:90-93
10. Dodick D, Mauskop A, Elkind AH, DeGaryse R, Brin MF, Silberstein SD, BOTOX CDH Study Group (2005) Botulinum toxin type A for the prophylaxis of chronic daily headache: Subgroup analysis of patients not receiving other prophylactic medications: A randomized, double-blind, placebo controlled study. Headache 45:315-324
11. Ambrosini A (2007) Occipital nerve stimulation for intractable cluster headache. Lancet 369:163-1365
12. Pascual J (2006) Good news for chronic migraine. J Headache Pain 7:185-187